Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Moderna Inc (MRNA)

Moderna Inc (MRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,959,810
  • Shares Outstanding, K 390,734
  • Annual Sales, $ 3,236 M
  • Annual Income, $ -3,561 M
  • EBIT $ -3,463 M
  • EBITDA $ -3,369 M
  • 60-Month Beta 1.11
  • Price/Sales 3.04
  • Price/Cash Flow N/A
  • Price/Book 1.01

Options Overview Details

View History
  • Implied Volatility 58.82% (-1.52%)
  • Historical Volatility 72.34%
  • IV Percentile 10%
  • IV Rank 9.48%
  • IV High 104.55% on 04/08/25
  • IV Low 54.03% on 08/06/25
  • Expected Move (DTE 7) 1.52 (5.97%)
  • Put/Call Vol Ratio 1.18
  • Today's Volume 39,280
  • Volume Avg (30-Day) 78,124
  • Put/Call OI Ratio 0.79
  • Today's Open Interest 977,812
  • Open Int (30-Day) 1,006,585
  • Expected Range 23.97 to 27.01

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 23 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -2.73
  • Number of Estimates 9
  • High Estimate -2.07
  • Low Estimate -3.15
  • Prior Year -2.50
  • Growth Rate Est. (year over year) -9.20%

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.28 +14.45%
on 11/21/25
27.10 -5.90%
on 11/12/25
+1.94 (+8.23%)
since 11/05/25
3-Month
22.28 +14.45%
on 11/21/25
29.45 -13.41%
on 10/08/25
+0.36 (+1.43%)
since 09/05/25
52-Week
22.28 +14.45%
on 11/21/25
48.92 -47.87%
on 01/07/25
-17.44 (-40.61%)
since 12/05/24

Most Recent Stories

More News
The Mid-Week Brief: Labor Market Cracks as Small-Caps Stage Comeback

The narrative on Wall Street shifted dramatically this week. What began as a post-holiday hangover on Monday has evolved into a full-blown “bad news is good news” rally by Thursday morning. The catalyst?...

GOOGL : 318.02 (+0.13%)
AAPL : 279.72 (-0.35%)
AVGO : 383.40 (+0.62%)
DG : 125.61 (+0.26%)
COIN : 270.87 (-1.16%)
MSFT : 481.04 (+0.04%)
^DOGEUSD : 0.143074 (-2.90%)
PSTG : 71.42 (-1.08%)
TSLA : 452.33 (-0.48%)
IRBT : 3.58 (+18.15%)
^BTCUSD : 90,449.55 (-1.88%)
GME : 22.93 (-0.09%)
3 Stocks Under $50 That Fall Short

3 Stocks Under $50 That Fall Short

ENOV : 27.76 (-0.72%)
CRI : 31.20 (-2.92%)
MRNA : 25.50 (+0.04%)
Stock Index Futures Gain as Investors Recover Risk Appetite

December S&P 500 E-Mini futures (ESZ25) are up +0.27%, and December Nasdaq 100 E-Mini futures (NQZ25) are up +0.39% this morning, signaling a rebound from yesterday’s sell-off on Wall Street as investor...

MSTR : 182.90 (-1.67%)
CRWD : 513.54 (+0.08%)
AVGO : 383.40 (+0.62%)
BAYN.D.DX : 33.555 (+0.13%)
CRDO : 180.70 (-0.12%)
MDB : 395.09 (-0.41%)
NQZ25 : 25,642.00 (+0.08%)
COIN : 270.87 (-1.16%)
PSTG : 71.42 (-1.08%)
SNPS : 463.20 (-0.12%)
WBD : 25.35 (+3.30%)
ESZ25 : 6,868.00 (+0.02%)
Is Moderna Stock Underperforming the Nasdaq?

Moderna has continued to underperform the Nasdaq Composite over the past year, and analysts remain cautious about the stock’s prospects.

$NASX : 23,505.14 (+0.22%)
BBIO : 75.32 (+0.75%)
MRNA : 25.50 (+0.04%)
Stocks Retreat as Bond Yields Rise

The S&P 500 Index ($SPX ) (SPY ) on Monday closed down by -0.53%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.90%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.36%....

MSTR : 182.90 (-1.67%)
MPC : 190.15 (+0.38%)
GLXY : 27.15 (-1.52%)
LVS : 66.40 (-0.72%)
WYNN : 125.72 (-4.42%)
$IUXX : 25,581.70 (-0.10%)
COIN : 270.87 (-1.16%)
ZNH26 : 112-230 (unch)
SHOP : 162.01 (-0.18%)
SION : 40.88 (-0.68%)
ESZ25 : 6,868.00 (+0.02%)
FANG : 159.01 (-0.31%)
Stocks Fall as Rising Bond Yields Spark Risk-Off Sentiment

The S&P 500 Index ($SPX ) (SPY ) today is down by -0.28%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.29%. December E-mini...

MSTR : 182.90 (-1.67%)
MPC : 190.15 (+0.38%)
CVX : 152.44 (+0.12%)
GLXY : 27.15 (-1.52%)
LVS : 66.40 (-0.72%)
WYNN : 125.72 (-4.42%)
$IUXX : 25,581.70 (-0.10%)
COIN : 270.87 (-1.16%)
ZNH26 : 112-230 (unch)
SHOP : 162.01 (-0.18%)
OXY : 42.62 (-0.12%)
SION : 40.88 (-0.68%)
Stocks Pressured by Higher Bond Yields

The S&P 500 Index ($SPX ) (SPY ) today is down by -0.59%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.40%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.97%. December E-mini...

MSTR : 182.90 (-1.67%)
MPC : 190.15 (+0.38%)
CVX : 152.44 (+0.12%)
GLXY : 27.15 (-1.52%)
LVS : 66.40 (-0.72%)
WYNN : 125.72 (-4.42%)
$IUXX : 25,581.70 (-0.10%)
COIN : 270.87 (-1.16%)
ZNH26 : 112-230 (unch)
SHOP : 162.01 (-0.18%)
OXY : 42.62 (-0.12%)
SION : 40.88 (-0.68%)
Clover Health, GoodRx, Moderna, UFP Technologies, and Masimo Shares Are Soaring, What You Need To Know

Clover Health, GoodRx, Moderna, UFP Technologies, and Masimo Shares Are Soaring, What You Need To Know

UFPT : 216.50 (+0.12%)
GDRX : 2.77 (+0.73%)
MASI : 143.02 (+0.53%)
MRNA : 25.50 (+0.04%)
CLOV : 2.67 (+0.34%)
Moderna Analyst Day Highlights Pipeline Progress and Business Strategy Updates

Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026

MRNA : 25.50 (+0.04%)
Moderna Secures $1.5 Billion Five-Year Credit Facility from Ares Management

Non-dilutive financing from premier lender bolsters strong balance sheet and provides increased flexibility

MRNA : 25.50 (+0.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Moderna, Inc. is a clinical-stage pharmaceutical company, primarily focused on discovering and developing messenger RNA (mRNA) based therapies. The company's mRNA based COVID-19 vaccine, Spikevax (mRNA-1273), is approved for use in adults in the United States. The vaccine is also authorized for emergency...

See More

Key Turning Points

3rd Resistance Point 27.22
2nd Resistance Point 26.56
1st Resistance Point 26.02
Last Price 25.50
1st Support Level 24.83
2nd Support Level 24.17
3rd Support Level 23.63

See More

52-Week High 48.92
Fibonacci 61.8% 38.74
Fibonacci 50% 35.60
Fibonacci 38.2% 32.46
Last Price 25.50
52-Week Low 22.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar